The in vitro expression of ABCG2, at the transcription and at post-translational level, was significantly decreased in isogenic U87MG human glioblastoma cell lines by PD153035 (an EGFR antagonist) [36]. The gene discussed is ABCG2; the disease is glioblastoma.